4d Pharma Share Discussion Threads

[showmethemoneyhoney01] 09/10/2020 07:33

Much more favourable price imo. Covid 19 news, Oncology news rerate and then fund raise to get funds and plenty of liquidity in the US. Min $3 a share fund raise I would guess.

[kcowe] 09/10/2020 06:38

100-200 million dollars .. that would be a lot of dilution if not at a more favourable price ..

[showmethemoneyhoney01] 09/10/2020 05:07

The Nasdaq listing will involve a large fund raise imo. Expect it to be Q1 2021 and could be $100-200m imo.

[realist1950] 08/10/2020 23:11

A year to the day.

I would not rule out an update on this.....amongst the many others we are due.

Regulars will know what all those are....so I wont labour the point this evening.



4d Pharma PLC Collaboration with MSD
08/10/2019 7:00am
UK Regulatory (RNS & others)

4d Pharma (LSE:DDDD)
Historical Stock Chart

From Oct 2018 to Oct 2020
Click Here for more 4d Pharma Charts.
TIDMDDDD

RNS Number : 0611P

4d Pharma PLC

08 October 2019

Regulatory

4D pharma plc

(the "Company" or "4D")

4D pharma collaborates with MSD to develop Live Biotherapeutics for vaccines

4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announces that the Company has entered into a research collaboration and option to license agreement with MSD, the tradename of Merck & Co., Inc., Kenilworth, NJ, USA, to discover and develop Live Biotherapeutics ("LBPs") for vaccines.

Under the terms of the agreement 4D's proprietary MicroRx(R) platform will be paired with MSD's expertise in the development and commercialisation of novel vaccines, to discover and develop LBPs as vaccines in up to three undisclosed indications. 4D has the right, subject to certain conditions, to cause MSD to purchase $5 million in ordinary shares in 4D during the first 12 months of the collaboration. In addition to an upfront cash payment, for each indication, 4D will be eligible to receive up to $347.5 million in option exercise and development and regulatory milestone payments, plus tiered royalties on annual net sales of any licensed products derived from the collaboration. MSD will be responsible for development, manufacturing and commercialisation following the exercise of any of its exclusive options.

Duncan Peyton, 4D's Chief Executive Officer, commented: "This research collaboration agreement brings together 4D's innovation in the microbiome space and MSD's track record of developing cutting-edge vaccines. MSD and 4D have worked closely combining world leading science to develop a workplan to advance the understanding of this field, with the aim of generating a new class of vaccines in areas of high unmet need."

Daria Hazuda, Chief Scientific Officer of MSD's Exploratory Science Center and MSD's Vice President of Infectious Diseases and Vaccines Discovery Research, commented: "A key element of our focus in the Exploratory Science Center is the evaluation of emerging new areas of biology that have the potential to offer major beneficial impact to human health. By applying 4D's MicroRx(R) technology we hope to gain meaningful insights into the role for the host microbiome in modulating the immune response and ultimately protection conferred by vaccines."

[mam fach] 08/10/2020 22:58

Whatever happened yesterday is disgraceful.
Not by any means a bad rns.
By sheer luck I sold at profit on Monday,
simply because I wanted to top up on another share.
Would be interested if anyone can explain what exactly happened.

[1sjh] 08/10/2020 21:48

Ps.I have warrents in many companies with between 9 and 12 months in which to choose if or not to take them i would really be hoping to take the warrents if I had double bubble.. certainly no rush (I dont have in 4d) if I had warrents in 4d id of been looking at £2 before I took em or id wait, essentially its a freehold. Not sure when the time limit is for taking warrents as I believe this was on the earlier placing than I was involved with.

[1sjh] 08/10/2020 21:31

The last placing was at 35p why you can easy double that and place at 70p. I bought 25k shares at 35p average sold at 150p. The last of them I sold because its quite obvious there is not a great deal of cash at hand, spring 2021 was the time set for this run out. The Blautix report was not all that impressive. Im not being negative only realistic all these companies need cash and I for one will be pleased to help 4d on their journey by buying in again. With a aim to break even next year another placing or 2 will surely take place between now and 2022.

[candlestick1] 08/10/2020 21:03

Dont think the Company gets a say as to when the warrants are converted.

[g2theary] 08/10/2020 20:37

I'd argue that's not a "big" short... got in these big at 100p will buy more if they fall to that tomorrow... long term these are a beaut :)))

[kcowe] 08/10/2020 20:25

Why place , 22million warrants to convert at a pound ... That opportunity was not taken as yet .

[nicbw01] 08/10/2020 20:06

not a big short. 812k shares. we had 30m traded the other day which was nearly 25% of the company.

[1sjh] 08/10/2020 20:03

Shorting makes sense as likely placing will come soon.

[ozzywalker] 08/10/2020 19:59

Big short on 4D https://twitter.com/shortdatauk/status/1314232841903968256?s=21

[thepaddedcell] 08/10/2020 19:56

DDDD securing a high profile partner for phase 3 IBS trials will give the share price a boost. I'm sure they will be in discussion with potential partners as we speak. The final trials and subsequent approvals will be some way off in the future by which time more substantial goals will have been met. Still an excellent medium to longer term investment especially with a NASDAK / dual listing !

[the stigologist] 08/10/2020 19:33

Apt



Reminder 4D's HIGHLIGHTS from Final Rseults. No mention of IBS.




Vaccines - still due update 1 year on !

[1sjh] 08/10/2020 19:30

Be a good time for a fund raiser now. At 70p id be interested.

[welshboy] 08/10/2020 18:32

Thanks Stig - still mulling where we are after yesterdays announcement...............

[the stigologist] 08/10/2020 18:25

welshboy you can always fail Phase III because whilst 4D and their Big Pharma partner will try to construct a favourable regulatory bar which they can easily cross they will have to get the protocol approved by the FDA who will set the bar higher and have their own expectations.

that is my understanding of how it works anyway

[welshboy] 08/10/2020 18:22

Given the IBS 2 result cannot see any reason it will fail stage 3............market reaction is crazy...............Pob Lwc to you all.....................

[the stigologist] 08/10/2020 18:18

That's why 'good' and 'bad' were in inverted commas

Thanks Daveweld for recognising my mysticmegness ha ha

I did expect a more rapid bounce off the 50 day MA but I didn't appreciate just how over-leveraged the traders in 4D were and the resultant damage to the psychology

However I think the newsflow catalysts going forward should reawaken the 'animal spirits' and the liquidity sloshing around in other stocks will eventually find itself back here

[eeza] 08/10/2020 18:12

It was a good IBS II result - but taken badly.

[blueball] 08/10/2020 17:50

Watch SERES its not stopping.

[daveweld2] 08/10/2020 17:47

Anyone unhappy with recent share action should read the below post 2 days ago from one of our posters was spelt out in black and white with crystal ball like accuracy..."Current thinking in the Boiler Room'Bad' Phase II IBS we see an attempt on 50 day MA 110p ish level(I'd expect a rapid bounce off that level as market repositions for coming COVID19 and Cancer readouts, NASDAQ listing and initiation of process for Neuro-degeneration clinical trials)'Good' Phase II IBS we break above the 'fragile' and 'facile' 200 week Moving Average of c.200p with targets of 250-400p"

[kcowe] 08/10/2020 17:25

Price will be on the up again in a few weeks .. nothing to see here for now.